BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20201737)

  • 1. Endosomal disruptors in non-viral gene delivery.
    Minchin RF; Yang S
    Expert Opin Drug Deliv; 2010 Mar; 7(3):331-9. PubMed ID: 20201737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral vector-mediated gene transfer for CNS disease.
    Snyder BR; Boulis NM; Federici T
    Expert Opin Biol Ther; 2010 Mar; 10(3):381-94. PubMed ID: 20132059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances with the use of bio-inspired vectors towards creation of artificial viruses.
    McCarthy HO; Wang Y; Mangipudi SS; Hatefi A
    Expert Opin Drug Deliv; 2010 Apr; 7(4):497-512. PubMed ID: 20151849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes.
    Varga CM; Tedford NC; Thomas M; Klibanov AM; Griffith LG; Lauffenburger DA
    Gene Ther; 2005 Jul; 12(13):1023-32. PubMed ID: 15815703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral-based gene delivery and regulated gene expression for targeted cancer therapy.
    Lu Y; Madu CO
    Expert Opin Drug Deliv; 2010 Jan; 7(1):19-35. PubMed ID: 19947888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-viral gene therapy: polycation-mediated DNA delivery.
    Thomas M; Klibanov AM
    Appl Microbiol Biotechnol; 2003 Jul; 62(1):27-34. PubMed ID: 12719940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid vector designs to control the delivery, fate and expression of transgenes.
    Lam PY; Breakefield XO
    J Gene Med; 2000; 2(6):395-408. PubMed ID: 11199260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art.
    Bondì ML; Craparo EF
    Expert Opin Drug Deliv; 2010 Jan; 7(1):7-18. PubMed ID: 20017658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel system for mitigation of ectopic transgene expression induced by adenoviral vectors.
    Reynolds PN; Holmes MD; Adachi Y; Kaliberova L; Curiel DT
    Gene Ther; 2001 Aug; 8(16):1271-5. PubMed ID: 11509961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards safe, non-viral therapeutic gene expression in humans.
    Glover DJ; Lipps HJ; Jans DA
    Nat Rev Genet; 2005 Apr; 6(4):299-310. PubMed ID: 15761468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-viral and viral vectors for gene therapy.
    Boulaiz H; Marchal JA; Prados J; Melguizo C; Aránega A
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):3-22. PubMed ID: 16171561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a multifunctional PEG-based gene delivery system containing nuclear localization signals and endosomal escape peptides.
    Moore NM; Sheppard CL; Sakiyama-Elbert SE
    Acta Biomater; 2009 Mar; 5(3):854-64. PubMed ID: 18926782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo.
    Steinwaerder DS; Lieber A
    Gene Ther; 2000 Apr; 7(7):556-67. PubMed ID: 10819570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of plasmid DNA-based non-viral gene medicine.
    Nishikawa M; Takakura Y; Hashida M
    Adv Genet; 2005; 53():47-68. PubMed ID: 16240990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound-mediated gene delivery.
    Yoon CS; Park JH
    Expert Opin Drug Deliv; 2010 Mar; 7(3):321-30. PubMed ID: 20166854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycation gene delivery systems: escape from endosomes to cytosol.
    Cho YW; Kim JD; Park K
    J Pharm Pharmacol; 2003 Jun; 55(6):721-34. PubMed ID: 12841931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the gene delivery efficacies of pH-sensitive cationic lipids via endosomal protonation: a chemical biology investigation.
    Singh RS; Gonçalves C; Sandrin P; Pichon C; Midoux P; Chaudhuri A
    Chem Biol; 2004 May; 11(5):713-23. PubMed ID: 15157882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.
    Douglas KL
    Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic gene therapy. Present situation and future perspective.
    Gottschalk U; Chan S
    Arzneimittelforschung; 1998 Nov; 48(11):1111-20. PubMed ID: 9850435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.